1989660-59-4
1989660-59-4
Chemical Structure
Ethosuximide-d5
- CAS 番号: 1989660-59-4
- Formula:C7H6D5NO2
- Molecular Weight:146.20
IUPAC Name: 3-(ethyl-d5)-3-methylpyrrolidine-2,5-dione
InChIKey: HAPOVYFOVVWLRS-WNWXXORZSA-N
SMILES: O=C(C(C)(C([2H])([2H])C([2H])([2H])[2H])C1)NC1=O
Biological Activity: Ethosuximide-d5 is deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel.
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ethosuximide-d5 | Ethosuximide-d5 is deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide (Standard) | ≥98% | Ethosuximide (Standard) is the analytical standard of Ethosuximide. This product is intended for research and analytical applications. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-d3 | Ethosuximide-d3 is the deuterium labeled Ethosuximide. Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide-13C, d3 | Ethosuximide-13C, d3 is the 13C- and deuterium labeled Ethosuximide (HY-B1378). Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ethosuximide | 99.35% | Ethosuximide, a widely prescribed anti-epileptic agent, improves the phenotypes of multiple neurodegenerative disease models and blocks the low voltage activated T-type calcium channel. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
